141 related articles for article (PubMed ID: 29925734)
21. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
Zhou YX; Shi Z; Singh P; Yin H; Yu YN; Li L; Walsh MP; Gui Y; Zheng XL
J Cell Physiol; 2016 Feb; 231(2):393-402. PubMed ID: 26129946
[TBL] [Abstract][Full Text] [Related]
22. Exercise training attenuated the PKB and GSK-3 dephosphorylation in the myocardium of ZDF rats.
Lajoie C; Calderone A; Trudeau F; Lavoie N; Massicotte G; Gagnon S; Béliveau L
J Appl Physiol (1985); 2004 May; 96(5):1606-12. PubMed ID: 14698990
[TBL] [Abstract][Full Text] [Related]
23. GSK-3 at the heart of cardiometabolic diseases: Isoform-specific targeting is critical to therapeutic benefit.
Umbarkar P; Ruiz Ramirez SY; Toro Cora A; Tousif S; Lal H
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166724. PubMed ID: 37094727
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
25. Expression and regulation of glycogen synthase kinase 3 in human neutrophils.
Giambelluca MS; Cloutier N; Rollet-Labelle E; Boilard E; Pouliot M
Int J Biochem Cell Biol; 2013 Nov; 45(11):2660-5. PubMed ID: 24035907
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of GSK-3 to induce cardiomyocyte proliferation: a recipe for in situ cardiac regeneration.
Singh AP; Umbarkar P; Guo Y; Force T; Gupte M; Lal H
Cardiovasc Res; 2019 Jan; 115(1):20-30. PubMed ID: 30321309
[TBL] [Abstract][Full Text] [Related]
27. Natural and synthetic bioactive inhibitors of glycogen synthase kinase.
Khan I; Tantray MA; Alam MS; Hamid H
Eur J Med Chem; 2017 Jan; 125():464-477. PubMed ID: 27689729
[TBL] [Abstract][Full Text] [Related]
28. A new strategy for studying protein kinase B and its three isoforms. Role of protein kinase B in phosphorylating glycogen synthase kinase-3, tuberin, WNK1, and ATP citrate lyase.
Sale EM; Hodgkinson CP; Jones NP; Sale GJ
Biochemistry; 2006 Jan; 45(1):213-23. PubMed ID: 16388597
[TBL] [Abstract][Full Text] [Related]
29. Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging.
Pandey MK; DeGrado TR
Theranostics; 2016; 6(4):571-93. PubMed ID: 26941849
[TBL] [Abstract][Full Text] [Related]
30. Glycogen synthase kinase-3beta activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells.
Lee KY; Koh SH; Noh MY; Park KW; Lee YJ; Kim SH
Brain Res; 2007 Jan; 1129(1):89-99. PubMed ID: 17157278
[TBL] [Abstract][Full Text] [Related]
31. Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015).
Palomo V; Martinez A
Expert Opin Ther Pat; 2017 Jun; 27(6):657-666. PubMed ID: 27828716
[TBL] [Abstract][Full Text] [Related]
32. Glycogen synthase kinase 3 in Wnt signaling pathway and cancer.
Tejeda-Muñoz N; Robles-Flores M
IUBMB Life; 2015 Dec; 67(12):914-22. PubMed ID: 26600003
[TBL] [Abstract][Full Text] [Related]
33. Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation.
Neumann M; Klar S; Wilisch-Neumann A; Hollenbach E; Kavuri S; Leverkus M; Kandolf R; Brunner-Weinzierl MC; Klingel K
Oncogene; 2011 May; 30(21):2485-92. PubMed ID: 21217772
[TBL] [Abstract][Full Text] [Related]
34. Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles.
Galliher-Beckley AJ; Williams JG; Collins JB; Cidlowski JA
Mol Cell Biol; 2008 Dec; 28(24):7309-22. PubMed ID: 18838540
[TBL] [Abstract][Full Text] [Related]
35. Targeting glycogen synthase kinase-3β to prevent hyperoxia-induced lung injury in neonatal rats.
Hummler SC; Rong M; Chen S; Hehre D; Alapati D; Wu S
Am J Respir Cell Mol Biol; 2013 May; 48(5):578-88. PubMed ID: 23328640
[TBL] [Abstract][Full Text] [Related]
36. Targeting GSK-3 family members in the heart: a very sharp double-edged sword.
Cheng H; Woodgett J; Maamari M; Force T
J Mol Cell Cardiol; 2011 Oct; 51(4):607-13. PubMed ID: 21163265
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.
Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML
Basic Res Cardiol; 2009 Nov; 104(6):653-67. PubMed ID: 19588183
[TBL] [Abstract][Full Text] [Related]
38. Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium.
Tan J; Geng L; Yazlovitskaya EM; Hallahan DE
Cancer Res; 2006 Feb; 66(4):2320-7. PubMed ID: 16489037
[TBL] [Abstract][Full Text] [Related]
39. Deletion of glycogen synthase kinase-3β in cartilage results in up-regulation of glycogen synthase kinase-3α protein expression.
Gillespie JR; Ulici V; Dupuis H; Higgs A; Dimattia A; Patel S; Woodgett JR; Beier F
Endocrinology; 2011 May; 152(5):1755-66. PubMed ID: 21325041
[TBL] [Abstract][Full Text] [Related]
40. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways.
Yin Z; Gao H; Wang H; Li L; Di C; Luan R; Tao L
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):756-63. PubMed ID: 19207715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
